Clinical Trial Update: A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated cediranib in combination with olaparib for ovarian cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Cediranib (Cediranib)
• Olaparib (Olaparib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED